SPC
ARKG icon

Sigma Planning Corp’s ARK Genomic Revolution ETF ARKG Stock Holding History

Sigma Planning Corp’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$515K Buy
12,249
+1,395
+13% +$44.4K 0.01% 900
2026
Q1 		$287K Buy
10,854
+42
+0.4% +$1.23K 0.01% 1072
2025
Q4 		$313K Buy
10,812
+3,074
+40% +$92.3K 0.01% 1004
2025
Q3 		$215K Buy
+7,738
New +$196K 0.01% 1188
2024
Q3 		– Sell
-9,111
Closed -$214K – 1214
2024
Q2 		$214K Sell
9,111
-1,757
-16% -$44.3K 0.01% 1061
2024
Q1 		$313K Buy
+10,868
New +$327K 0.01% 943
2023
Q4 		– Sell
-11,867
Closed -$331K – 856
2023
Q3 		$331K Buy
11,867
+109
+0.9% +$3.56K 0.01% 884
2023
Q2 		$401K Sell
11,758
-2,222
-16% -$69.8K 0.01% 827
2023
Q1 		$420K Buy
13,980
+303
+2% +$9.39K 0.01% 875
2022
Q4 		$386K Sell
13,677
-2,995
-18% -$95.1K 0.01% 872
2022
Q3 		$548K Buy
16,672
+936
+6% +$34.4K 0.02% 695
2022
Q2 		$496K Sell
15,736
-3,857
-20% -$135K 0.02% 752
2022
Q1 		$900K Sell
19,593
-25,263
-56% -$1.2M 0.03% 582
2021
Q4 		$2.75M Sell
44,856
-6,366
-12% -$440K 0.08% 264
2021
Q3 		$3.83M Sell
51,222
-12,174
-19% -$1.02M 0.12% 194
2021
Q2 		$5.86M Sell
63,396
-13,146
-17% -$1.12M 0.17% 124
2021
Q1 		$6.79M Sell
76,542
-27,350
-26% -$2.71M 0.22% 103
2020
Q4 		$9.69M Buy
103,892
+4,059
+4% +$323K 0.33% 63
2020
Q3 		$6.36M Sell
99,833
-9,212
-8% -$540K 0.25% 78
2020
Q2 		$5.69M Buy
109,045
+96,557
+773% +$4.14M 0.25% 79
2020
Q1 		$391K Sell
12,488
-3,031
-20% -$101K 0.02% 563
2019
Q4 		$520K Buy
15,519
+4,291
+38% +$136K 0.02% 586
2019
Q3 		$331K Buy
11,228
+3,673
+49% +$119K 0.02% 724
2019
Q2 		$260K Buy
+7,555
New +$242K 0.01% 800

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Sigma Planning Corp's ARKG Position: Q2 2026 in Review

Sigma Planning Corp increased its ARK Genomic Revolution ETF (ARKG) stake by 13% in Q2 2026, buying an estimated $44.4K and bringing the position to 12,249 shares worth $515K. The position accounts for 0.01% of the portfolio, ranked #900.

Sigma Planning Corp first reported a position in ARKG in Q2 2019 and has held it in 24 quarters since. The position peaked at $9.69M in Q4 2020. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Sigma Planning Corp held 12,249 shares of ARK Genomic Revolution ETF worth $515K as of Q2 2026.
  • Sigma Planning Corp bought 1,395 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $44.4K.
  • ARK Genomic Revolution ETF made up 0.01% of Sigma Planning Corp's portfolio in Q2 2026, its #900 holding.
  • Sigma Planning Corp first reported a position in ARK Genomic Revolution ETF in Q2 2019 and has held it in 24 quarters since.
  • Sigma Planning Corp's ARK Genomic Revolution ETF position peaked at $9.69M in Q4 2020.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Sigma Planning Corp's 13F filing for Q2 2026, filed 7 Aug 2026.